FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997334145> ?p ?o ?g. }

• W2997334145 endingPage "7197" @default.
• W2997334145 startingPage "7185" @default.
• W2997334145 abstract "// Caroline K. S&#x00F8;gaard 1 , 2 , Anala Nepal 1 , Voin Petrovic 1 , Animesh Sharma 3 , Nina-Beate Liabakk 1 , Tonje S. Steigedal 1 and Marit Otterlei 1 , 2 , 4 1 Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway 2 Clinic of Surgery, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway 3 Proteomics and Modomics Experimental Core Facility (PROMEC), NTNU, Trondheim, Norway 4 APIM Therapeutics A/S, Trondheim, Norway Correspondence to: Marit Otterlei, email: marit.otterlei@ntnu.no Keywords: APIM; multi-targeting therapy; signaling pathways; autophagy; cancer Received: May 30, 2019     Accepted: September 24, 2019     Published: December 31, 2019 ABSTRACT Receptor tyrosine kinases (RTKs), such as HER2 and/or EGFR are important therapeutic targets in multiple cancer cells. Low and/or short response to targeted therapies are often due to activation of compensatory signaling pathways, and therefore a combination of kinase inhibitors with other anti-cancer therapies have been proposed as promising strategies. PCNA is recently shown to have non-canonical cytosolic roles, and targeting PCNA with a cell-penetrating peptide containing the PCNA-interacting motif APIM is shown to mediate changes in central signaling pathways such as PI3K/Akt and MAPK, acting downstream of multiple RTKs. In this study, we show how targeting PCNA increased the anti-cancer activity of EGFR/HER2/VEGFR inhibition in vitro as well as in vivo. The combination treatment resulted in reduced tumor load and increased the survival compared to either single agent treatments. The combination treatment affected multiple cellular signaling responses not seen by EGFR/HER2/VEGFR inhibition alone, and changes were seen in pathways determining protein degradation, ER-stress, apoptosis and autophagy. Our results suggest that targeting the non-canonical roles of PCNA in cellular signaling have the potential to improve targeted therapies." @default.
• W2997334145 created "2020-01-10" @default.
• W2997334145 creator A5036039477 @default.
• W2997334145 creator A5054214702 @default.
• W2997334145 creator A5068589576 @default.
• W2997334145 creator A5069145196 @default.
• W2997334145 creator A5071136409 @default.
• W2997334145 creator A5083021239 @default.
• W2997334145 creator A5088541838 @default.
• W2997334145 date "2019-12-31" @default.
• W2997334145 modified "2023-10-06" @default.
• W2997334145 title "Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy" @default.
• W2997334145 cites W1033623824 @default.
• W2997334145 cites W1973814158 @default.
• W2997334145 cites W1986136524 @default.
• W2997334145 cites W1995454342 @default.
• W2997334145 cites W2000471416 @default.
• W2997334145 cites W2001381548 @default.
• W2997334145 cites W2001533423 @default.
• W2997334145 cites W2002865491 @default.
• W2997334145 cites W2013194895 @default.
• W2997334145 cites W2015081253 @default.
• W2997334145 cites W2042619042 @default.
• W2997334145 cites W2048110169 @default.
• W2997334145 cites W2056870028 @default.
• W2997334145 cites W2059317542 @default.
• W2997334145 cites W2060797544 @default.
• W2997334145 cites W2066559457 @default.
• W2997334145 cites W2068605146 @default.
• W2997334145 cites W2072747624 @default.
• W2997334145 cites W2075556417 @default.
• W2997334145 cites W2077804275 @default.
• W2997334145 cites W2082389654 @default.
• W2997334145 cites W2094302275 @default.
• W2997334145 cites W2119547813 @default.
• W2997334145 cites W2122008479 @default.
• W2997334145 cites W2122374677 @default.
• W2997334145 cites W2122683221 @default.
• W2997334145 cites W2133651123 @default.
• W2997334145 cites W2135581618 @default.
• W2997334145 cites W2139205106 @default.
• W2997334145 cites W2140452388 @default.
• W2997334145 cites W2146649673 @default.
• W2997334145 cites W2150276706 @default.
• W2997334145 cites W2159531864 @default.
• W2997334145 cites W2166802330 @default.
• W2997334145 cites W2170776626 @default.
• W2997334145 cites W2195310352 @default.
• W2997334145 cites W2402636472 @default.
• W2997334145 cites W2409436463 @default.
• W2997334145 cites W2428522048 @default.
• W2997334145 cites W2509701068 @default.
• W2997334145 cites W2528806911 @default.
• W2997334145 cites W2544360569 @default.
• W2997334145 cites W2567875376 @default.
• W2997334145 cites W2584634738 @default.
• W2997334145 cites W2586009033 @default.
• W2997334145 cites W2742889437 @default.
• W2997334145 cites W2743639018 @default.
• W2997334145 cites W2757364581 @default.
• W2997334145 cites W2790160098 @default.
• W2997334145 cites W2792071716 @default.
• W2997334145 cites W2795687223 @default.
• W2997334145 cites W2800106575 @default.
• W2997334145 cites W2803661638 @default.
• W2997334145 cites W2888629133 @default.
• W2997334145 cites W2906836536 @default.
• W2997334145 cites W4234586755 @default.
• W2997334145 cites W4292865245 @default.
• W2997334145 doi "https://doi.org/10.18632/oncotarget.27267" @default.
• W2997334145 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6944453" @default.
• W2997334145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31921382" @default.
• W2997334145 hasPublicationYear "2019" @default.
• W2997334145 type Work @default.
• W2997334145 sameAs 2997334145 @default.
• W2997334145 citedByCount "13" @default.
• W2997334145 countsByYear W29973341452020 @default.
• W2997334145 countsByYear W29973341452021 @default.
• W2997334145 countsByYear W29973341452022 @default.
• W2997334145 countsByYear W29973341452023 @default.
• W2997334145 crossrefType "journal-article" @default.
• W2997334145 hasAuthorship W2997334145A5036039477 @default.
• W2997334145 hasAuthorship W2997334145A5054214702 @default.
• W2997334145 hasAuthorship W2997334145A5068589576 @default.
• W2997334145 hasAuthorship W2997334145A5069145196 @default.
• W2997334145 hasAuthorship W2997334145A5071136409 @default.
• W2997334145 hasAuthorship W2997334145A5083021239 @default.
• W2997334145 hasAuthorship W2997334145A5088541838 @default.
• W2997334145 hasBestOaLocation W29973341451 @default.
• W2997334145 hasConcept C101544691 @default.
• W2997334145 hasConcept C121608353 @default.
• W2997334145 hasConcept C126322002 @default.
• W2997334145 hasConcept C143998085 @default.
• W2997334145 hasConcept C170493617 @default.
• W2997334145 hasConcept C2781230642 @default.
• W2997334145 hasConcept C502942594 @default.
• W2997334145 hasConcept C62478195 @default.
• W2997334145 hasConcept C71924100 @default.

• next